Abstract:Breast cancer is the most common malignant disease in women worldwide. According to the World Health Organization and the International Agency for Research on Cancer, it accounts for 25.1% of all cancer cases in women. Intracystic breast cancer is one of the most rare and difficult to diagnose forms of this disease. Due to this improving existing methods of breast cancer diagnosis and developing new ways for the early detection of this pathology are of great importance. The aim of the study is to evaluate the effectiveness of new methods for breast cancer diagnosis – an improved technique of puncture–needle biopsy under ultrasound control and a hybrid technology for assessing the local metabolism of mammary tumors. Materials and methods. The article presents the results of examining 67 female patients with intracystic breast cancer using the traditional technique of puncture-needle biopsy and a new method of cytological diagnosis of this disease. The article presents the pilot results of using the hybrid technology for evaluating local metabolism of mammary gland tumors in 22 patients with suspected breast cancer to clarify the diagnosis and assess the prognosis using optical diagnostic methods: fluorescence spectroscopy (at wavelengths of fluorescence excitation of 365 and 450 nm) and diffuse reflectance spectroscopy (with a source of polychromatic radiation). Results. The sensitivity of puncture-needle biopsy performed according to the traditional method in the diagnosis of intracystic breast cancer was 81.8%, and the sensitivity of the improved method was 97.06% (p < 0.05). To asses reliably the effectiveness of the hybrid technology for determining the local metabolism of tumors in the diagnosis of breast cancer, examination of a larger number of patients is required. Among the patients examined using the optical diagnostic methods, the following data were obtained: the redox index in the tumor was 0.67±0.10 relative units, in the surrounding tissue – 0.77±0.14, tissue saturation in the tumor – 64±14%, in the surrounding tissue – 68±9%. Two cases of breast cancer in patients prior to the start of treatment and after 6 courses of neoadjuvant polychemotherapy are considered separately. The following data were obtained: the redox index in the tumor in the patient without treatment was 0.53± 0.01 relative units, in the patient after 6 courses of neoadjuvant therapy – 0.81±0.01 relative units; the value of tissue saturation in the tumor in the patient without treatment – 71±1%, in the patient after 6 courses of neoadjuvant therapy – 64± 2%. To asses reliably the effectiveness of the hybrid technology for determining the local metabolism of tumors in the diagnosis of breast cancer and to have the opportunity to assess the prognosis for the disease course, examination of a larger number of patients is required. Conclusions. A new method of cytological diagnosis of cancer in a breast cyst using ozone-oxygen mixture proved to be more effective than the traditional method, which proves the expediency of its use in order to improve the diagnosis of this pathology at the preoperative stage. To solve the question of the expediency of using the technique of spectrophotometry of tumor tissues in patients with breast cancer in order to assess the effectiveness of chemotherapy, a larger number of women under examination and a period of their follow-up for 3–5 years are required.

Study of correlation between biochemical indicators and radiological diagnostic parameters of breast cancer.

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples

Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas

HYBRID MINIMALLY INVASIVE TECHNOLOGIES IN DIAGNOSING AND ASSESSING THE PROGNOSIS FOR THE COURSE OF THE DISEASE IN PATIENTS WITH BREAST CANCER: PUNCTURE-NEEDLE BIOPSY USING OZONE-OXYGEN MIXTURE AND TISSUE SPECTROPHOTOMETRY TECHNIQUE

Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI

Assessment of YKL-40, lipid profile, antioxidant status, and some trace elements in benign and malignant breast proliferation

Association of mammographic and sonographic findings with prognostic molecular factors and hormone receptor expression in malignant breast lesions

Method for Assessing Local Metabolism of Mammary Tumors Based on Multimodal Optical Technology

Correlations of Imaging and Therapy in Breast Cancer Based on Molecular Patterns: An Important Issue in the Diagnosis of Breast Cancer

Correlation analysis between ultrasonography and mammography with other risk factors related to breast cancer

Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer

Serum metabolite and metal ions profiles for breast cancer screening

Breast cancer diagnosis: Imaging techniques and biochemical markers

Pilot study: A simple CAD-based tool to detect breast cancer on MRI of the breast

The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters

The Effectiveness of Radiological Methods in Predicting Pathological Complete Response After Neoadjuvant Therapy in Locally Advanced Breast Cancer Patients

Correlation Between Pharmacokinetic Analysis of DCE-MRI and Breast Image Reporting and Data System (BIRADS) Classification.

Combination of circulating miR-145-5p/miR-191-5p as biomarker for breast cancer detection

Correlation and predictive value of pathological complete response and ultrasound characteristic parameters in neoadjuvant chemotherapy for breast